{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:29:07Z","timestamp":1790094547440,"version":"4.0.1"},"reference-count":36,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2022.25098","type":"journal-article","created":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T15:01:41Z","timestamp":1659538901000},"page":"e2225098","source":"Crossref","is-referenced-by-count":41,"title":["Analysis of Clinical Features, Diagnostic Tests, and Biomarkers in Patients With Suspected Creutzfeldt-Jakob Disease, 2014-2021"],"prefix":"10.1001","volume":"5","author":[{"given":"Dror","family":"Shir","sequence":"first","affiliation":[{"name":"Department of Neurology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn B.","family":"Lazar","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic, Jacksonville, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Graff-Radford","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen J.","family":"Aksamit","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy K.","family":"Cutsforth-Gregory","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T.","family":"Jones","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Botha","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay K.","family":"Ramanan","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Prusinski","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic, Jacksonville, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Porter","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic, Jacksonville, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory S.","family":"Day","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic, Jacksonville, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2022,8,3]]},"reference":[{"issue":"25","key":"zoi220698r1","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1056\/NEJM199712183372508","article-title":"Transmissible spongiform encephalopathies.","volume":"337","author":"Haywood","year":"1997","journal-title":"N Engl J Med"},{"issue":"2","key":"zoi220698r3","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1001\/archneurol.2008.533","article-title":"Characteristics of established and proposed sporadic Creutzfeldt-Jakob disease variants.","volume":"66","author":"Appleby","year":"2009","journal-title":"Arch Neurol"},{"issue":"3","key":"zoi220698r4","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1212\/01.WNL.0000134555.59460.5D","article-title":"Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt-Jakob disease.","volume":"63","author":"Shiga","year":"2004","journal-title":"Neurology"},{"issue":"6","key":"zoi220698r5","first-page":"1551","article-title":"Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high sensitivity and specificity for diagnosis.","volume":"26","author":"Young","year":"2005","journal-title":"AJNR Am J Neuroradiol"},{"issue":"20","key":"zoi220698r6","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1212\/WNL.0b013e31821a4439","article-title":"Diffusion-weighted MRI hyperintensity patterns differentiate CJD from other rapid dementias.","volume":"76","author":"Vitali","year":"2011","journal-title":"Neurology"},{"key":"zoi220698r7","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2020.102523","article-title":"Multimodal MRI staging for tracking progression and clinical-imaging correlation in sporadic Creutzfeldt-Jakob disease.","volume":"30","author":"Sacco","year":"2021","journal-title":"Neuroimage Clin"},{"issue":"5","key":"zoi220698r8","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1002\/(ISSN)1531-8249","article-title":"Diagnostic value of periodic complexes in Creutzfeldt-Jakob disease.","volume":"56","author":"Steinhoff","year":"2004","journal-title":"Ann Neurol"},{"issue":"Pt 9","key":"zoi220698r9","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1093\/brain\/awl159","article-title":"Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease.","volume":"129","author":"Collins","year":"2006","journal-title":"Brain"},{"issue":"2","key":"zoi220698r10","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s13760-021-01596-3","article-title":"A meta-analysis on RT-QuIC for the diagnosis of sporadic CJD.","volume":"121","author":"Chatzikonstantinou","year":"2021","journal-title":"Acta Neurol Belg"},{"issue":"14","key":"zoi220698r11","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1212\/WNL.0b013e31826d5fc3","article-title":"Evidence-based guideline: diagnostic accuracy of CSF 14-3-3 protein in sporadic Creutzfeldt-Jakob disease: report of the guideline development subcommittee of the American Academy of Neurology.","volume":"79","author":"Muayqil","year":"2012","journal-title":"Neurology"},{"issue":"4","key":"zoi220698r12","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s00401-017-1683-0","article-title":"Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and A\u00df42 levels.","volume":"133","author":"Lattanzio","year":"2017","journal-title":"Acta Neuropathol"},{"issue":"1","key":"zoi220698r13","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1136\/practneurol-2018-001935","article-title":"RT-QuIC: a new test for sporadic CJD.","volume":"19","author":"Green","year":"2019","journal-title":"Pract Neurol"},{"issue":"4","key":"zoi220698r14","doi-asserted-by":"publisher","first-page":"e331","DOI":"10.1212\/WNL.0000000000005860","article-title":"Validation and utilization of amended diagnostic criteria in Creutzfeldt-Jakob disease surveillance.","volume":"91","author":"Hermann","year":"2018","journal-title":"Neurology"},{"issue":"8","key":"zoi220698r15","doi-asserted-by":"publisher","first-page":"e1017","DOI":"10.1212\/WNL.0000000000010086","article-title":"Diagnosis of prion diseases by RT-QuIC results in improved surveillance.","volume":"95","author":"Rhoads","year":"2020","journal-title":"Neurology"},{"issue":"3","key":"zoi220698r16","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.1556","article-title":"Prevalence of surgical procedures at symptomatic onset of prion disease.","volume":"5","author":"Porter","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"22","key":"zoi220698r17","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1212\/01.wnl.0000431029.13491.59c","article-title":"A comparison of tau and 14-3-3 protein in the diagnosis of Creutzfeldt-Jakob disease.","volume":"80","author":"Karch","year":"2013","journal-title":"Neurology"},{"issue":"8","key":"zoi220698r18","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1001\/jamaneurol.2019.1071","article-title":"Association of blood and cerebrospinal fluid tau level and other biomarkers with survival time in sporadic Creutzfeldt-Jakob disease.","volume":"76","author":"Staffaroni","year":"2019","journal-title":"JAMA Neurol"},{"issue":"9","key":"zoi220698r19","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1001\/jamaneurol.2020.1319","article-title":"Evaluation of a new criterion for detecting prion disease with diffusion magnetic resonance imaging.","volume":"77","author":"Bizzi","year":"2020","journal-title":"JAMA Neurol"},{"issue":"12","key":"zoi220698r20","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.1007\/s00415-019-09537-0","article-title":"Diagnostic value of surrogate CSF biomarkers for Creutzfeldt-Jakob disease in the era of RT-QuIC.","volume":"266","author":"Abu-Rumeileh","year":"2019","journal-title":"J Neurol"},{"issue":"1","key":"zoi220698r22","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.46319","article-title":"Validation of revised international Creutzfeldt-Jakob disease surveillance network diagnostic criteria for sporadic Creutzfeldt-Jakob disease.","volume":"5","author":"Watson","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"3","key":"zoi220698r23","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S1474-4422(20)30477-4","article-title":"Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease.","volume":"20","author":"Hermann","year":"2021","journal-title":"Lancet Neurol"},{"issue":"7","key":"zoi220698r24","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1136\/jnnp.2006.094821","article-title":"Neuroimaging findings in human prion disease.","volume":"78","author":"Macfarlane","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Pt 9","key":"zoi220698r25","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1093\/brain\/awh575","article-title":"MRI in the diagnosis of sporadic Creutzfeldt-Jakob disease: a study on inter-observer agreement.","volume":"128","author":"Tschampa","year":"2005","journal-title":"Brain"},{"issue":"6","key":"zoi220698r26","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1001\/archneur.60.6.813","article-title":"Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease.","volume":"60","author":"Geschwind","year":"2003","journal-title":"Arch Neurol"},{"issue":"4","key":"zoi220698r27","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1212\/01.wnl.0000230159.67128.00","article-title":"CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease.","volume":"67","author":"Sanchez-Juan","year":"2006","journal-title":"Neurology"},{"issue":"9","key":"zoi220698r28","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1212\/WNL.55.9.1396","article-title":"Misleading results with the 14-3-3 assay for the diagnosis of Creutzfeldt-Jakob disease.","volume":"55","author":"Chapman","year":"2000","journal-title":"Neurology"},{"issue":"Pt 10","key":"zoi220698r29","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1093\/brain\/aws238","article-title":"Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt-Jakob disease and rapid dementias: a longitudinal multicentre study over 10 years.","volume":"135","author":"Stoeck","year":"2012","journal-title":"Brain"},{"issue":"1","key":"zoi220698r30","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/(ISSN)1531-8249","article-title":"Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease.","volume":"43","author":"Zerr","year":"1998","journal-title":"Ann Neurol"},{"issue":"Pt 10","key":"zoi220698r31","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1093\/brain\/awh249","article-title":"Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies.","volume":"127","author":"Pocchiari","year":"2004","journal-title":"Brain"},{"issue":"7","key":"zoi220698r32","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/0753-3322(94)90174-0","article-title":"Pathological tau proteins of Alzheimer\u2019s disease as a biochemical marker of neurofibrillary degeneration.","volume":"48","author":"Delacourte","year":"1994","journal-title":"Biomed Pharmacother"},{"issue":"10","key":"zoi220698r33","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41582-018-0058-z","article-title":"Neurofilaments as biomarkers in neurological disorders.","volume":"14","author":"Khalil","year":"2018","journal-title":"Nat Rev Neurol"},{"issue":"10","key":"zoi220698r34","doi-asserted-by":"publisher","first-page":"5955","DOI":"10.1038\/s41380-021-01045-w","article-title":"Evaluation of plasma tau and neurofilament light chain biomarkers in a 12-year clinical cohort of human prion diseases.","volume":"26","author":"Thompson","year":"2021","journal-title":"Mol Psychiatry"},{"key":"zoi220698r35","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1743-8454-5-14","article-title":"Cerebrospinal fluid markers in Creutzfeldt-Jakob disease.","volume":"5","author":"Skinningsrud","year":"2008","journal-title":"Cerebrospinal Fluid Res"},{"issue":"12","key":"zoi220698r36","doi-asserted-by":"publisher","first-page":"3514","DOI":"10.3390\/cells10123514","article-title":"NT1-tau is increased in CSF and plasma of CJD patients, and correlates with disease progression.","volume":"10","author":"Mengel","year":"2021","journal-title":"Cells"},{"key":"zoi220698r2","unstructured":"Centers for Disease Control and Prevention. Diagnostic Criteria: CDC\u2019s diagnostic criteria for Creutzfeldt-Jakob disease (CJD). Accessed January 9, 2021. https:\/\/www.cdc.gov\/prions\/cjd\/diagnostic-criteria.html"},{"key":"zoi220698r21","unstructured":"Appleby? BS, Cohen? ML. Creutzfeldt-Jakob disease. UpToDate. Accessed August 9, 2021. https:\/\/www.uptodate.com\/contents\/creutzfeldt-jakob-disease?search=cjd&source=search_result&selectedTitle=1~89&usage_type=default&display_rank=1"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2794883\/shir_2022_oi_220698_1658854828.95929.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T15:01:44Z","timestamp":1659538904000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2794883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,3]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.25098","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,3]]}}}